162 related articles for article (PubMed ID: 1690821)
61. Susceptibility of human monoclonal antibody-producing B cell lines to infection by human immunodeficiency virus.
Shepherd AJ; Boyd JE; Hogg CL; Aw D; James K
Hum Antibodies Hybridomas; 1992 Oct; 3(4):168-76. PubMed ID: 1335786
[TBL] [Abstract][Full Text] [Related]
62. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.
Ljunggren K; Karlson A; Fenyö EM; Jondal M
Clin Exp Immunol; 1989 Feb; 75(2):184-9. PubMed ID: 2649286
[TBL] [Abstract][Full Text] [Related]
63. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein.
Kowalski M; Bergeron L; Dorfman T; Haseltine W; Sodroski J
J Virol; 1991 Jan; 65(1):281-91. PubMed ID: 1702159
[TBL] [Abstract][Full Text] [Related]
64. Immortalized Epstein-Barr virus-positive B-cell lines obtained by prolonged culture of peripheral blood mononuclear cells from human immunodeficiency virus type 1-positive patients.
Ruibal-Ares B; Belmonte L; Baré P; Scolnik M; Palacios MF; Bayo-Hanza C; Galmarini CM; Mendez G; de Bracco MM
J Hum Virol; 2001; 4(4):200-13. PubMed ID: 11694848
[TBL] [Abstract][Full Text] [Related]
65. Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo.
Jurriaans S; de Ronde A; Dekker J; Cornelissen M; Goudsmit J
J Med Virol; 1995 Jan; 45(1):91-8. PubMed ID: 7714497
[TBL] [Abstract][Full Text] [Related]
66. Generation of alloantigen-stimulated anti-human immunodeficiency virus activity is associated with HLA-A*02 expression.
Grene E; Pinto LA; Cohen SS; Mac Trubey C ; Trivett MT; Simonis TB; Liewehr DJ; Steinberg SM; Shearer GM
J Infect Dis; 2001 Feb; 183(3):409-16. PubMed ID: 11133372
[TBL] [Abstract][Full Text] [Related]
67. In vivo administration of CD4-specific monoclonal antibody: effect on provirus load in rhesus monkeys chronically infected with the simian immunodeficiency virus of macaques.
Reimann KA; Cate RL; Wu Y; Palmer L; Olson D; Waite BC; Letvin NL; Burkly LC
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):517-25. PubMed ID: 7632466
[TBL] [Abstract][Full Text] [Related]
68. Stoichiometry of monoclonal antibody neutralization of T-cell line-adapted human immunodeficiency virus type 1.
Schønning K; Lund O; Lund OS; Hansen JE
J Virol; 1999 Oct; 73(10):8364-70. PubMed ID: 10482587
[TBL] [Abstract][Full Text] [Related]
69. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma.
Lo SC; Tsai S; Benish JR; Shih JW; Wear DJ; Wong DM
Science; 1991 Mar; 251(4997):1074-6. PubMed ID: 1705362
[TBL] [Abstract][Full Text] [Related]
70. Enhancement of retroviral infection in vitro by anti-Le(y) IgG: reversal by humanization of monoclonal mouse antibody.
Hansen JE; Sørensen AM; Arendrup M; Olofsson S; Nielsen JO; Janzek E; Nielsen C; Loibner H
APMIS; 1993 Sep; 101(9):711-8. PubMed ID: 7902106
[TBL] [Abstract][Full Text] [Related]
71. Inhibition of the reverse transcriptase activity and replication of human immunodeficiency virus type 1 by AS 101 in vitro.
Vonsover A; Loya S; Sredni B; Albeck M; Gotlieb-Stematsky T; Araf O; Hizi A
AIDS Res Hum Retroviruses; 1992 May; 8(5):613-23. PubMed ID: 1381205
[TBL] [Abstract][Full Text] [Related]
72. Induction of strong homotypic adhesion in human T cell lines positive with human T-cell leukemia virus type 1 by monoclonal antibodies to MHC class I and beta 2-microglobulin.
Furuse M; Fukudome K; Imai T; Uwabe K; Hinuma Y; Yoshie O
Cell Immunol; 1992 Sep; 143(2):298-309. PubMed ID: 1380895
[TBL] [Abstract][Full Text] [Related]
73. Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates.
Kessler JA; McKenna PM; Emini EA; Chan CP; Patel MD; Gupta SK; Mark GE; Barbas CF; Burton DR; Conley AJ
AIDS Res Hum Retroviruses; 1997 May; 13(7):575-82. PubMed ID: 9135875
[TBL] [Abstract][Full Text] [Related]
74. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.
Clark SJ; Saag MS; Decker WD; Campbell-Hill S; Roberson JL; Veldkamp PJ; Kappes JC; Hahn BH; Shaw GM
N Engl J Med; 1991 Apr; 324(14):954-60. PubMed ID: 1900576
[TBL] [Abstract][Full Text] [Related]
75. Syncytium induction by fresh HIV isolates: quantitative analysis using a transactivation beta-gal assay.
Emilie D; Maillot MC; Bonnerot C; Devergne O; Delfraissy JF; Nicolas JF; Galanaud P
AIDS; 1990 Aug; 4(8):791-7. PubMed ID: 1979746
[TBL] [Abstract][Full Text] [Related]
76. HIV type 1-specific cytotoxic T lymphocytes stimulate HLA class I and intercellular adhesion molecule type 1 expression and increase beta 2-microglobulin levels in vitro.
Jassoy C; Heinkelein M; Klinker H; Walker BD
AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1685-93. PubMed ID: 7888228
[TBL] [Abstract][Full Text] [Related]
77. A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates.
Benyoucef S; Hober D; Shen L; Ajana F; Gérard Y; Bocket-Mouton L; Mouton Y; Wattré P
Microbiol Immunol; 1996; 40(5):381-8. PubMed ID: 8805103
[TBL] [Abstract][Full Text] [Related]
78. Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection.
Tanaka R; Yoshida A; Murakami T; Baba E; Lichtenfeld J; Omori T; Kimura T; Tsurutani N; Fujii N; Wang ZX; Peiper SC; Yamamoto N; Tanaka Y
J Virol; 2001 Dec; 75(23):11534-43. PubMed ID: 11689635
[TBL] [Abstract][Full Text] [Related]
79. Relation between HIV-1 syncytium inhibition antibodies and clinical outcome in children.
Brenner TJ; Dahl KE; Olson B; Miller G; Andiman WA
Lancet; 1991 Apr; 337(8748):1001-5. PubMed ID: 1673167
[TBL] [Abstract][Full Text] [Related]
80. Human immunodeficiency virus type-1 envelope glycoprotein gp120 induces expression of fusion regulatory protein (FRP)-1/CD98 on CD4+ T cells: a possible regulatory mechanism of HIV-induced syncytium formation.
Suga S; Tsurudome M; Ito M; Ohgimoto S; Tabata N; Nishio M; Kawano M; Komada H; Ito M; Sakurai M; Ito Y
Med Microbiol Immunol; 1997 Mar; 185(4):237-43. PubMed ID: 9138296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
